S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 02:54 AM ET

PETV

PetVivo Holdings, Inc.

Price Chart
Latest Quote

$0.80

+0.02 (+2.56%)
Current Price
Previous Close $0.78
Open $0.80
Day High $0.80
Day Low $0.80
Volume 100
Fetched: 2026-06-20T06:54:07
Stock Information
Shares Outstanding 36.65M
Total Debt $71K
Cash Equivalents $168K
Revenue $1.11M
Net Income $-10.21M
Sector Healthcare
Industry Medical Devices
Market Cap $29.32M
EPS (TTM) $-0.38
Exchange OQX
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$29.67M
Sales$1.11M
Income$-10.21M
Book/sh$0.10
Cash/sh$0.00
Employees24
Financial Ratios
Quick Ratio0.41
Current Ratio1.40
Debt/Eq2.09
Returns & Margins
ROA-136.56%
ROE-739.94%
Gross Margin66.05%
Operating Margin-765.95%
Ownership
Insider Ownership51.20%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-1.07
P/S26.38
P/B8.16
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.78
SMA50$0.78
SMA200$0.96
RSI54.11
ATR0.0731
Shares Float26.69M
Short Float1.00%
Short Ratio4.45
Volatility1.26
Rel Volume0.13
Performance History
Week+0.00%
Month+0.13%
Quarter+1.27%
6 Months-31.03%
YTD-30.43%
Year+14.29%
3 Years-62.96%
5 Years-92.34%
10 Years-87.92%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $0.80 1,200
2026-06-17 $0.78 19,200
2026-06-16 $0.85 29,400
2026-06-15 $0.80 11,100
2026-06-12 $0.80 5,700
2026-06-11 $0.80 19,400
2026-06-10 $0.80 0
2026-06-09 $0.80 4,500
2026-06-08 $0.80 14,600
2026-06-05 $0.73 5,600
2026-06-04 $0.70 27,100
2026-06-03 $0.72 8,900
2026-06-02 $0.80 800
2026-06-01 $0.70 7,400
2026-05-29 $0.76 2,800
2026-05-28 $0.80 300
2026-05-27 $0.80 900
2026-05-26 $0.79 18,100
2026-05-22 $0.78 4,500
2026-05-21 $0.79 5,100
2026-05-20 $0.80 7,900
2026-05-19 $0.80 1,700
About PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Period:
Loading...
Income Statement (Annual)
Metric 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Revenue
Reconciled Cost Of Revenue $137,677 $101,823 $221,036 $201,154
Cost Of Revenue $137,677 $101,823 $221,036 $201,154
Total Revenue $1,132,533 $968,706 $917,162 $115,586
Operating Revenue $1,132,533 $968,706 $917,162 $115,586
Expenses
Interest Expense $359,408 $6,463 - -
Total Expenses $9,188,252 $11,590,046 $9,650,614 $5,172,114
Other Income Expense $15,962 $-327,492 - $31,680
Other Non Operating Income Expenses $56,399 $386,874 - -
Net Non Operating Interest Income Expense $-359,408 $-6,463 $15,844 $9,853
Interest Expense Non Operating $359,408 $6,463 - -
Operating Expense $9,050,575 $11,488,223 $9,429,578 $4,970,960
Selling And Marketing Expense $2,644,095 $3,399,666 $3,410,277 $1,347,585
General And Administrative Expense $4,823,230 $6,693,186 $5,022,943 $3,148,494
Total Other Finance Cost - $6,463 $-15,844 $-9,853
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Net Interest Income $-359,408 $-6,463 $15,844 $9,853
Normalized Income $-8,358,729 $-10,627,803 $-8,717,608 $-5,046,675
Net Income From Continuing And Discontinued Operation $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Total Operating Income As Reported $-8,055,720 $-10,621,340 $-8,733,452 $-5,056,528
Net Income Common Stockholders $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Net Income $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Net Income Including Noncontrolling Interests $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Net Income Continuous Operations $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Pretax Income $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Special Income Charges $66,076 $-327,492 $0 $31,680
Operating Income $-8,055,719 $-10,621,340 $-8,733,452 $-5,056,528
Gross Profit $994,856 $866,883 $696,126 $-85,568
Interest Income - - $15,844 $9,853
Interest Income Non Operating - - $15,844 $9,853
Per Share
Diluted EPS $-0.41 $-0.78 $-0.85 $-0.57
Basic EPS $-0.41 $-0.78 $-0.85 $-0.57
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-7,646,108 $-10,494,490 $-8,619,018 $-5,023,055
Total Unusual Items $-40,437 $-327,492 $0 $31,680
Total Unusual Items Excluding Goodwill $-40,437 $-327,492 $0 $31,680
Reconciled Depreciation $353,213 $126,850 $114,434 $65,153
EBITDA (Bullshit earnings) $-7,686,545 $-10,821,982 $-8,619,018 $-4,991,375
EBIT $-8,039,758 $-10,948,832 $-8,733,452 $-5,056,528
Diluted Average Shares $20,491,422 $13,969,754 $10,222,994 $8,760,877
Basic Average Shares $20,491,422 $13,969,754 $10,222,994 $8,760,877
Diluted NI Availto Com Stockholders $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Tax Provision $0 $0 $0 $0
Other Special Charges $-66,076 $327,492 - $-31,680
Gain On Sale Of Security $-106,513 - - -
Research And Development $1,583,250 $1,395,371 $996,358 $474,881
Selling General And Administration $7,467,325 $10,092,852 $8,433,220 $4,496,079
Other Gand A $4,823,230 $6,693,186 $5,022,943 $3,148,494
Gain On Sale Of Ppe - - - -
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Net Tangible Assets $2,245,523 $655,854 $686,376 $5,938,270
Total Assets $9,339,195 $3,115,253 $2,438,952 $7,427,332
Total Non Current Assets $3,729,628 $2,073,593 $1,014,972 $671,932
Non Current Prepaid Assets $27,490 $27,490 $27,490 $12,830
Goodwill And Other Intangible Assets $1,973,725 $30,099 $38,649 $48,452
Other Intangible Assets $1,973,725 $30,099 $38,649 $48,452
Current Assets $5,609,567 $1,041,660 $1,423,980 $6,755,400
Other Current Assets $3,801 $8,512 $4,694 -
Prepaid Assets $444,000 $537,000 $487,000 $547,664
Inventory $323,504 $390,076 $370,283 $98,313
Receivables $4,460,573 $18,669 $86,689 $2,596
Other Receivables $4,400,000 - - -
Accounts Receivable $60,573 $18,669 $86,689 $2,596
Cash Cash Equivalents And Short Term Investments $377,689 $87,403 $475,314 $6,106,827
Cash And Cash Equivalents $227,689 $87,403 $475,314 $6,106,827
Non Current Deferred Assets - - - $0
Restricted Cash - - - -
Debt
Net Debt $1,712,995 $83,289 - -
Total Debt $2,902,223 $1,365,040 $345,332 $332,851
Long Term Debt And Capital Lease Obligation $803,147 $1,016,930 $260,247 $267,124
Long Term Debt $5,442 $13,171 $239,832 $27,201
Current Debt And Capital Lease Obligation $2,099,076 $348,110 $85,085 $65,727
Current Debt $1,935,242 $157,521 $6,936 $6,549
Other Current Borrowings $1,935,242 $157,521 $6,936 $6,549
Liabilities
Total Liabilities Net Minority Interest $5,119,947 $2,429,300 $1,713,927 $1,440,610
Total Non Current Liabilities Net Minority Interest $803,147 $1,016,930 $260,247 $267,124
Current Liabilities $4,316,800 $1,412,370 $1,453,680 $1,173,486
Other Current Liabilities $448,089 - - -
Payables And Accrued Expenses $1,769,635 $1,064,260 $1,368,595 $1,107,759
Payables $821,081 $821,230 $588,713 $323,384
Accounts Payable $821,081 $821,230 $588,713 $323,384
Current Notes Payable - - - $0
Interest Payable - - - $332,238
Total Tax Payable - - - $452,137
Equity
Common Stock Equity $4,211,203 $685,953 $725,025 $5,986,722
Preferred Stock Equity $8,045 - - -
Total Equity Gross Minority Interest $4,219,248 $685,953 $725,025 $5,986,722
Stockholders Equity $4,219,248 $685,953 $725,025 $5,986,722
Retained Earnings $-91,198,490 $-82,799,324 $-71,844,029 $-63,126,421
Other Equity Interest - - $137,500 -
Other
Ordinary Shares Number $24,181,537 $17,058,620 $10,950,220 $9,988,361
Share Issued $24,181,537 $17,058,620 $10,950,220 $9,988,361
Tangible Book Value $2,237,478 $655,854 $686,376 $5,938,270
Invested Capital $6,151,887 $856,645 $971,793 $6,020,472
Working Capital $1,292,767 $-370,710 $-29,700 $5,581,914
Capital Lease Obligations $961,539 $1,194,348 $98,564 $299,101
Total Capitalization $4,224,690 $699,124 $964,857 $6,013,923
Additional Paid In Capital $95,385,511 $83,468,218 $72,420,604 $69,103,155
Capital Stock $32,227 $17,059 $10,950 $9,988
Common Stock $24,182 $17,059 $10,950 $9,988
Preferred Stock $8,045 $0 $0 $0
Long Term Capital Lease Obligation $797,705 $1,003,759 $20,415 $239,923
Current Capital Lease Obligation $163,834 $190,589 $78,149 $59,178
Current Accrued Expenses $948,554 $243,030 $779,882 $784,375
Net PPE $1,728,413 $2,016,004 $948,833 $610,650
Accumulated Depreciation $-545,806 $-427,590 $-309,290 $-204,659
Gross PPE $2,274,219 $2,443,594 $1,258,123 $815,309
Leases $424,041 $418,041 $216,159 $216,159
Other Properties $1,694,873 $1,880,736 $920,232 $522,252
Machinery Furniture Equipment $155,305 $144,817 $121,732 $76,898
Properties $0 $0 $0 $0
Finished Goods $21,782 $35,442 $13,159 $11,889
Work In Process $41,540 $20,289 $53,398 $22,960
Raw Materials $260,182 $334,345 $303,726 $63,464
Other Short Term Investments $150,000 $0 - -
Treasury Shares Number - $0 - -
Buildings And Improvements - - $317,981 $299,101
Inventories Adjustments Allowances - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Free Cash Flow
Free Cash Flow $-5,885,387 $-7,728,692 $-7,218,417 $-4,358,141
Operating Activities
Operating Cash Flow $-5,321,953 $-7,419,588 $-6,794,483 $-4,174,957
Cash Flow From Continuing Operating Activities $-5,321,953 $-7,419,588 $-6,794,483 $-4,174,957
Operating Gains Losses $225,559 $148,492 - $-31,680
Investing Activities
Capital Expenditure $-563,434 $-309,104 $-423,934 $-183,184
Investing Cash Flow $-563,434 $-309,104 $-423,934 $-183,184
Cash Flow From Continuing Investing Activities $-563,434 $-309,104 $-423,934 $-183,184
Financing Activities
Issuance Of Capital Stock $3,868,100 $6,527,439 $1,526,745 $10,200,881
Financing Cash Flow $6,025,673 $7,340,781 $1,586,904 $10,441,390
Cash Flow From Continuing Financing Activities $6,025,673 $7,340,781 $1,586,904 $10,441,390
Net Preferred Stock Issuance $1,818,000 $0 - -
Preferred Stock Issuance $1,818,000 $0 - -
Net Common Stock Issuance $2,050,100 $6,527,439 $1,526,745 $10,200,881
Common Stock Issuance $2,050,100 $6,527,439 $1,526,745 $10,200,881
Net Other Financing Charges - - - $280,163
Other
Repayment Of Debt $-7,427 $-6,658 $-6,399 $-81,685
Issuance Of Debt $2,165,000 $820,000 $0 $0
Interest Paid Supplemental Data $8,360 $1,573 $2,842 $9,642
Income Tax Paid Supplemental Data $0 $0 - -
End Cash Position $227,689 $87,403 $475,314 $6,106,827
Beginning Cash Position $87,403 $475,314 $6,106,827 $23,578
Changes In Cash $140,286 $-387,911 $-5,631,513 $6,083,249
Net Issuance Payments Of Debt $2,157,573 $813,342 $-6,399 $-81,685
Net Long Term Debt Issuance $2,157,573 $813,342 $-6,399 $-81,685
Long Term Debt Payments $-7,427 $-6,658 $-6,399 $-81,685
Long Term Debt Issuance $2,165,000 $820,000 $0 $0
Net Intangibles Purchase And Sale $-500,000 $0 $0 $-29,154
Purchase Of Intangibles $-500,000 $0 $0 $-29,154
Net PPE Purchase And Sale $-63,434 $-309,104 $-423,934 $-154,030
Purchase Of PPE $-63,434 $-309,104 $-423,934 $-154,030
Change In Working Capital $277,809 $171,635 $-161,677 $-200,511
Change In Other Current Liabilities $-179,641 $0 - -
Change In Payables And Accrued Expense $335,072 $81,538 $260,836 $109,066
Change In Accrued Expense $63,622 $0 $0 $-35,808
Change In Interest Payable $63,622 $0 $0 $1,000
Change In Payable $271,450 $81,538 $260,836 $144,874
Change In Account Payable $271,450 $81,538 $260,836 $144,874
Change In Prepaid Assets $97,710 $41,870 $-66,450 $-208,668
Change In Inventory $66,572 $-19,793 $-271,970 $-98,313
Change In Receivables $-41,904 $68,020 $-84,093 $-2,596
Changes In Account Receivables $-41,904 $68,020 $-84,093 $-2,596
Other Non Cash Items $739,862 $863,352 $507,600 $304,180
Stock Based Compensation $1,480,770 $2,225,378 $1,462,768 $702,896
Depreciation Amortization Depletion $353,213 $126,850 $114,434 $65,153
Depreciation And Amortization $353,213 $126,850 $114,434 $65,153
Depreciation $353,213 $126,850 $104,631 -
Gain Loss On Investment Securities $290,616 - - -
Gain Loss On Sale Of PPE $1,018 $0 - -
Net Income From Continuing Operations $-8,399,166 $-10,955,295 $-8,717,608 $-5,014,995
Proceeds From Stock Option Exercised - $0 $66,558 $42,031
Amortization Cash Flow - $8,550 $9,803 -
Amortization Of Intangibles - $8,550 $9,803 -
Change In Other Working Capital - - - -
Fetched: 2026-02-02